Atlas Trials

StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis

Clinical trial NCT06767150 · RECRUITING

Trial details

NCT number
NCT06767150
Sponsor
University Hospital, Toulouse
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Postmenopausal Osteoporosis
Start date
2025-10-02
Primary completion
2030-10-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.